COVID-19-Associated Paediatric Inflammatory Multisystem
Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort
Trial (PIMS-TS INT)

J 2023

COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)

MUSILOVÁ, Tereza, Jakub JONAS, Tomas GOMBALA, Jan DAVID, Filip FENCL et. al.

Basic information

Original name

COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)

Authors

MUSILOVÁ, Tereza (203 Czech Republic, belonging to the institution), Jakub JONAS (203 Czech Republic), Tomas GOMBALA (203 Czech Republic), Jan DAVID (203 Czech Republic), Filip FENCL (203 Czech Republic), Eva KLABUSAYOVÁ (203 Czech Republic, belonging to the institution), Jozef KLUČKA (703 Slovakia, belonging to the institution), Milan KRATOCHVÍL (703 Slovakia), Pavla HAVRÁNKOVÁ (203 Czech Republic, belonging to the institution), Adela VRTKOVA (203 Czech Republic), Kateřina SLABÁ (203 Czech Republic, belonging to the institution), Jana TUČKOVÁ (203 Czech Republic, belonging to the institution), Lukáš HOMOLA (203 Czech Republic), Petr ŠTOURAČ (203 Czech Republic, belonging to the institution) and Tomáš VYMAZAL (203 Czech Republic)

Edition

Children, BASEL, MDPI, 2023, 2227-9067

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30209 Paediatrics

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 2.400 in 2022

RIV identification code

RIV/00216224:14110/23:00131037

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.3390/children10020348

UT WoS

000938953200001

Keywords in English

PIMS-TS; COVID-19; SARS-CoV-2; paediatric patient; post-COVID syndrome

Abstract

V originále

Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) is a new disease in children and adolescents that occurs after often asymptomatic or mild COVID-19. It can be manifested by different clinical symptomatology and varying severity of disease based on multisystemic inflammation. The aim of this retrospective cohort trial was to describe the initial clinical presentation, diagnostics, therapy and clinical outcome of paediatric patients with a diagnosis of PIMS-TS admitted to one of the 3 PICUs. All paediatric patients who were admitted to the hospital with a diagnosis of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) during the study period were enrolled in the study. A total of 180 patients were analysed. The most common symptoms upon admission were fever (81.6%, n = 147), rash (70.6%, n = 127), conjunctivitis (68.9%, n = 124) and abdominal pain (51.1%, n = 92). Acute respiratory failure occurred in 21.1% of patients (n = 38). Vasopressor support was used in 20.6% (n = 37) of cases. Overall, 96.7% of patients (n = 174) initially tested positive for SARS-CoV-2 IgG antibodies. Almost all patients received antibiotics during in-hospital stays. No patient died during the hospital stay or after 28 days of follow-up. Initial clinical presentation and organ system involvement of PIMS-TS including laboratory manifestations and treatment were identified in this trial. Early identification of PIMS-TS manifestation is essential for early treatment and proper management of patients.

Links

MUNI/A/1105/2022, interní kód MU

Name: Efektivita ventilace během kardiopulmonální resuscitace u dětí: simulační komparativní studie

Investor: Masaryk University, Effectivity of ventilation during simulated paediatric CPR: simulatation-based comparative study

MUNI/A/1109/2022, interní kód MU

Name: Hloubka anestezie: prospektivní observační studie

Investor: Masaryk University, The Depth of Paediatric Anaesthesia: Observational Trial

Citovat

MUSILOVÁ, Tereza, Jakub JONAS, Tomas GOMBALA, Jan DAVID, Filip FENCL, Eva KLABUSAYOVÁ, Jozef KLUČKA, Milan KRATOCHVÍL, Pavla HAVRÁNKOVÁ, Adela VRTKOVA, Kateřina SLABÁ, Jana TUČKOVÁ, Lukáš HOMOLA, Petr ŠTOURAČ and Tomáš VYMAZAL. COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT). Children. BASEL: MDPI, 2023, vol. 10, No 2, p. 1-15. ISSN 2227-9067. Available from: https://dx.doi.org/10.3390/children10020348.

@article{2293083,
   author = {Musilová, Tereza and Jonas, Jakub and Gombala, Tomas and David, Jan and Fencl, Filip and Klabusayová, Eva and Klučka, Jozef and Kratochvíl, Milan and Havránková, Pavla and Vrtkova, Adela and Slabá, Kateřina and Tučková, Jana and Homola, Lukáš and Štourač, Petr and Vymazal, Tomáš},
   article_location = {BASEL},
   article_number = {2},
   doi = {http://dx.doi.org/10.3390/children10020348},
   keywords = {PIMS-TS; COVID-19; SARS-CoV-2; paediatric patient; post-COVID syndrome},
   language = {eng},
   issn = {2227-9067},
   journal = {Children},
   title = {COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)},
   url = {https://www.mdpi.com/2227-9067/10/2/348},
   volume = {10},
   year = {2023}
}

TY  - JOUR
ID  - 2293083
AU  - Musilová, Tereza - Jonas, Jakub - Gombala, Tomas - David, Jan - Fencl, Filip - Klabusayová, Eva - Klučka, Jozef - Kratochvíl, Milan - Havránková, Pavla - Vrtkova, Adela - Slabá, Kateřina - Tučková, Jana - Homola, Lukáš - Štourač, Petr - Vymazal, Tomáš
PY  - 2023
TI  - COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)
JF  - Children
VL  - 10
IS  - 2
SP  - 1-15
EP  - 1-15
PB  - MDPI
SN  - 22279067
KW  - PIMS-TS
KW  - COVID-19
KW  - SARS-CoV-2
KW  - paediatric patient
KW  - post-COVID syndrome
UR  - https://www.mdpi.com/2227-9067/10/2/348
N2  - Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS) is a new disease in children and adolescents that occurs after often asymptomatic or mild COVID-19. It can be manifested by different clinical symptomatology and varying severity of disease based on multisystemic inflammation. The aim of this retrospective cohort trial was to describe the initial clinical presentation, diagnostics, therapy and clinical outcome of paediatric patients with a diagnosis of PIMS-TS admitted to one of the 3 PICUs. All paediatric patients who were admitted to the hospital with a diagnosis of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) during the study period were enrolled in the study. A total of 180 patients were analysed. The most common symptoms upon admission were fever (81.6%, n = 147), rash (70.6%, n = 127), conjunctivitis (68.9%, n = 124) and abdominal pain (51.1%, n = 92). Acute respiratory failure occurred in 21.1% of patients (n = 38). Vasopressor support was used in 20.6% (n = 37) of cases. Overall, 96.7% of patients (n = 174) initially tested positive for SARS-CoV-2 IgG antibodies. Almost all patients received antibiotics during in-hospital stays. No patient died during the hospital stay or after 28 days of follow-up. Initial clinical presentation and organ system involvement of PIMS-TS including laboratory manifestations and treatment were identified in this trial. Early identification of PIMS-TS manifestation is essential for early treatment and proper management of patients.
ER  -

MUSILOVÁ, Tereza, Jakub JONAS, Tomas GOMBALA, Jan DAVID, Filip FENCL, Eva KLABUSAYOVÁ, Jozef KLUČKA, Milan KRATOCHVÍL, Pavla HAVRÁNKOVÁ, Adela VRTKOVA, Kateřina SLABÁ, Jana TUČKOVÁ, Lukáš HOMOLA, Petr ŠTOURAČ and Tomáš VYMAZAL. COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT). \textit{Children}. BASEL: MDPI, 2023, vol.~10, No~2, p.~1-15. ISSN~2227-9067. Available from: https://dx.doi.org/10.3390/children10020348.

Detailed Information on Publication Record